Novo Nordisk says it’s cutting 9,000 workers amid increased competition for its obesity drug WegovySeptember 10, 2025
Share Facebook Twitter Pinterest Email Copy Link Premium Membership Required You must be a Premium member to access this content.Join NowAlready a member? Log in here